Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLVT
CLVT logo

CLVT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Clarivate PLC (CLVT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.740
1 Day change
2.24%
52 Week Range
4.770
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Clarivate PLC (CLVT) is not a strong buy for a beginner, long-term investor at this time. The stock shows weak financial performance, bearish technical indicators, and lacks significant positive catalysts. While hedge funds are increasing their positions, the overall sentiment and financial metrics do not support a compelling long-term investment case.

Technical Analysis

The MACD is positive and expanding, which is a bullish signal. However, the RSI indicates a neutral trend, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 2.655), which could limit further upside in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
8

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 182.82% increase in buying over the last quarter.

Neutral/Negative Catalysts

  • The company faces risks from AI disintermediation and uncertainty around the potential sale of its Life Sciences and Healthcare segment. Analysts have consistently lowered price targets, reflecting concerns about execution and market risks. Additionally, there is no recent news or congress trading data to suggest strong interest or confidence in the stock.

Financial Performance

The company's Q4 2025 financials show a decline in revenue (-6.94% YoY), net income (-101.62% YoY), EPS (-100% YoY), and gross margin (-3.83% YoY). These metrics indicate weak financial health and growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets significantly, with ratings ranging from Neutral to Underweight. The current price target consensus is below the stock's recent trading price, reflecting bearish sentiment.

Wall Street analysts forecast CLVT stock price to rise
5 Analyst Rating
Wall Street analysts forecast CLVT stock price to rise
0 Buy
3 Hold
2 Sell
Moderate Sell
Current: 2.680
sliders
Low
3
Averages
3.9
High
5
Current: 2.680
sliders
Low
3
Averages
3.9
High
5
Citi
Neutral
downgrade
AI Analysis
2026-03-04
Reason
Citi
Price Target
AI Analysis
2026-03-04
downgrade
Neutral
Reason
Citi lowered the firm's price target on Clarivate to $2.80 from $4.25 and keeps a Neutral rating on the shares.
RBC Capital
Sector Perform
downgrade
$5 -> $3
2026-02-26
Reason
RBC Capital
Price Target
$5 -> $3
2026-02-26
downgrade
Sector Perform
Reason
Yesterday, RBC Capital lowered the firm's price target on Clarivate to $3 from $5 and keeps a Sector Perform rating on the shares. The company delivered solid free cash flow growth and guided to about 10% free cash flow growth at the midpoint in FY26, though the firm's price target reflects the concerns around ongoing AI disintermediation risk, and execution around a potential Life Sciences and Healthcare segment sale, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLVT
Unlock Now

People Also Watch